SCOPUS 정보 검색 플랫폼

Annals of Surgery

Volumn 244, Issue 2, 2006, Pages 327-328

Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib [5]

(1) Cahill, Ronan A a

a University College Cork and INFANT Centre (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ROFECOXIB;

ANGIOGENESIS; CARDIOTOXICITY; CELL ADHESION; COLON ANASTOMOSIS; DRUG EFFECT; FIBROBLAST; FRACTURE; HUMAN; INTESTINE MUCOSA; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STOMACH ULCER; SURGICAL WOUND; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ABDOMEN; ADHESIONS; ANGIOGENESIS INHIBITORS; ANIMALS; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; INTESTINAL OBSTRUCTION; MICE; PYRAZOLES; SULFONAMIDES;

EID: 33748121238 PISSN: 00034932 EISSN: None Source Type: Journal
DOI: 10.1097/01.sla.0000230021.24473.cf Document Type: Letter

Times cited : (7)

References (8)

1
- 21444453926
- Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib
- Greene AK, Alwayn IP, Nose V, et al. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg. 2005;242:140-146.
- (2005) Ann Surg , vol.242 , pp. 140-146
- Greene, A.K.¹ Alwayn, I.P.² Nose, V.³

2
- 0032750920
- Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
- Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 1999;5:1418-1423.
- (1999) Nat Med , vol.5 , pp. 1418-1423
- Jones, M.K.¹ Wang, H.² Peskar, B.M.³

3
- 0033997088
- Impaired mucosal defense to acute colonic injury in mice lacking cyclo-oxygenase-1 or cyclo-oxygenase-2
- Morteau O, Morham SG, Sellon R, et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclo-oxygenase-1 or cyclo-oxygenase-2. J Clin Invest. 2000;105:469-478.
- (2000) J Clin Invest , vol.105 , pp. 469-478
- Morteau, O.¹ Morham, S.G.² Sellon, R.³

4
- 0035999429
- Cyclo-oxygenase 2 function is essential for bone fracture healing
- Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res. 2002;17:963-976.
- (2002) J Bone Miner Res , vol.17 , pp. 963-976
- Simon, A.M.¹ Manigrasso, M.B.² O'Connor, J.P.³

5
- 10244235295
- Effects of a selective cyclo-oygenase-2 inhibitor on colonic anastomotic and skin wound integrity
- Cahill RA, Sheehan KM, Scanlon RW, et al. Effects of a selective cyclo-oygenase-2 inhibitor on colonic anastomotic and skin wound integrity. Br J Surg. 2004;91:1613-1618.
- (2004) Br J Surg , vol.91 , pp. 1613-1618
- Cahill, R.A.¹ Sheehan, K.M.² Scanlon, R.W.³

6
- 0025830065
- The influence of NSAIDs on experimental intestinal anastomoses
- Mastboom WJ, Hendriks T, van Elteren P, et al. The influence of NSAIDs on experimental intestinal anastomoses. Dis Colon Rectum. 1991;34:236-243.
- (1991) Dis Colon Rectum , vol.34 , pp. 236-243
- Mastboom, W.J.¹ Hendriks, T.² Van Elteren, P.³

7
- 18944402178
- Rofecoxib for rheumatoid arthritis
- Garner SE, Fidan DD, Frankish RR, et al. Rofecoxib for rheumatoid arthritis. Cochrane Database Syst Rev. 2005;1:CD003685.
- (2005) Cochrane Database Syst Rev , vol.1
- Garner, S.E.¹ Fidan, D.D.² Frankish, R.R.³

8
- 9944262983
- Risk of cardiovascular events and rofecoxib: Cumulative meta-analysis
- Juni P, Nartey L, Reichenbach S, et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364:2021-2029.
- (2004) Lancet , vol.364 , pp. 2021-2029
- Juni, P.¹ Nartey, L.² Reichenbach, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.